Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
37.76 (1y: +27%)
Market Cap 58.43 B P/E(ttm) 11.60
Enterprise Value 57.01 B P/B 2.20
ABT- NYSE (USA)
Abbott Laboratories
  • Currently 3.5/5
Business Predictability Rank: 3.5-Star
Back Testing Results:
Average gain of all 3.5-Star stocks: 9.3% per year.
% of Stocks that are in still loss if held for 10yrs: 9%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$37.76
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58,426Revenue $M39,874Net Margin (%)15.0Z-Score2.4
Enterprise Value $M57,011EPS $3.3Operating Margin %20.3F-Score0
P/E(ttm))11.6Cash Flow Per Share $6.7Pre-tax Margin (%)15.7Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %10.3Quick Ratio1.3Cash flow > EarningsN
Price/Sales1.55-y EBITDA Growth Rate %7.6Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %0ROA % (ttm)8.9Higher Current Ratio y-yN
Dividend Yield %3.4Insider Buy (3m)1ROE % (ttm)22.3Less Shares Outstanding y-yN
Payout Ratio %50.5Shares Outstanding M1,571ROI % (ttm)21.4Gross Margin Increase y-yN

Gurus Latest Trades with ABT

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
ABT2013-03-31 Add0.62%$31.34 - $35.32
($33.84)		 $ 37.7612%Add 127.45%4,434,735
ABT2012-09-30 Add0.2%$63.95 - $69.84
($66.33)		 $ 37.76-43%Add 18.71%2,218,879
ABT2012-06-30 Reduce-1.71%$59.49 - $63.4
($61.55)		 $ 37.76-39%Reduce -58.9%1,869,118
ABT2011-06-30 Add2.05%$49.37 - $54
($51.91)		 $ 37.76-27%Add 213.79%6,320,870
ABT2011-03-31 Buy 0.84%$45.16 - $49.07
($47.35)		 $ 37.76-20%New holding, 2014393 sh.2,014,393
ABT2007-03-31 Sold Out $49.33 - $55.44
($52.5)		 $ 37.76-28%Sold Out0
ABT2006-12-31 Buy $45.63 - $48.64
($47.2)		 $ 37.76-20%New holding, 9525 sh.9,525
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 7

ABT is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT George Soros 2013-03-311,140,7520.070.47+93.84%
ABT PRIMECAP Management 2013-03-3111,683,7470.740.61+58.55%
ABT Mario Gabelli 2013-03-3184,2150.010.02+40.97%
ABT John Hussman 2013-03-31401,7500.030.52
ABT Dodge & Cox 2013-03-3137,86500-0.39%
ABT Mason Hawkins 2013-03-3114,554,6780.932.3-1.35%
ABT Vanguard Health Care Fund 2013-03-319,347,7000.61.3-7.9%
ABT Meridian Funds 2013-03-31000Sold Out
ABT Joel Greenblatt 2013-03-31000Sold Out
ABT Daniel Loeb 2013-03-31000Sold Out
ABT Scott Black 2012-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Grace, MarkSenior Officer 2013-02-20Sell2,000$5.37597.95view
LINDER GREG WDirector 2013-02-19Sell1,314$34.767.83view
ASHLEY RICHARD WExecutive Vice President 2013-02-19Sell4,672$34.797.73view
Blaser Brian JExecutive Vice President 2013-02-19Sell1,022$34.797.73view
Landgraf John CExecutive Vice President 2013-02-19Sell3,066$34.787.76view
Fussell Stephen RSenior Vice President 2013-02-19Sell3,066$34.87.7view
Mason Heather LSenior Vice President 2013-02-19Sell3,066$34.797.73view
Simhambhatla Murthy VSenior Vice President 2013-02-19Sell402$34.787.76view
Warmuth Michael JExecutive Vice President 2013-02-19Sell3,066$34.787.76view
Fussell Stephen RSenior Vice President 2013-02-01Sell9,690$33.8910.59view

Press Releases about ABT:

Quarterly/Annual Reports about ABT:

News about abt:

Articles On GuruFocus.com
Guru Stocks at 52-Week Highs Apr 15 2013 
14 Cheapest Dividend-Paying Large Caps As of March 2013 Mar 23 2013 
Weekly 52 Week Highs: ABBV, ABT, YUM, AET Feb 11 2013 
Should dividend investors hold on to Abbott and Abbvie following the split? Feb 01 2013 
Reconsidering Abbott Labs (ABT) And AbbVie (ABBV) Jan 18 2013 
Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012 
Abbott Laboratories (ABT) Dividend Stock Analysis Dec 27 2012 
9 High-Yielding Mega-Cap Stocks Dec 26 2012 
Abbott Laboratories: Quality Dividend Aristocrat for Long Term Dividends Dec 21 2012 
Dividend Stocks I Purchased Over the Past Two Months Dec 19 2012 

More From Our Partners
CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog May 22 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK